Actively Recruiting
Real-World Study Evaluating Safety and Performance of Getinges Beating Heart Devices in Beating Heart Coronary Artery Bypass Surgery
Led by Maquet Cardiovascular · Updated on 2026-09-11
200
Participants Needed
7
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are conducting an observational study to collect data on the performance and safety of Getinges Beating Heart product family used during open-heart coronary artery bypass graft CABG surgery. The study focuses on patients undergoing beating heart CABG, where the heart continues to beat during the procedure, and aims to evaluate device-related adverse events, serious adverse events, and technical success. Participants will undergo the planned beating heart CABG surgery using at least one of Getinges devices, such as the Vacuum Stabilizer System, Vacuum Positioner System, BlowerMister, or Proximal Seal System. These devices assist with heart positioning, vessel immobilization, blood clearance, and clampless hemostasis during surgery. The surgery and device use follow the standard of care, and no additional study-specific procedures are required. Throughout the study, information will be collected from the time of surgery until hospital discharge, typically averaging about 7 days. Researchers will monitor device safety and effectiveness by tracking adverse events and technical success during and shortly after surgery. Participants will not have extra visits or interventions beyond their routine care, and the study data will be gathered from hospital records during the stay.
CONDITIONS
Brief Title
Getinge's Beating Heart Product Family Post-Market Clinical Follow-up (PMCF) Study
Research Team
S
Sr. Manager, Clinical Affairs
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here